Stevanato Group to Present at Upcoming Investor Conference

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that management will present at the Bank of America Global Healthcare Conference in London at 9:05 a.m. (BST) on September 15, 2022.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Friday, September 9, 2022
Information
Tags: 
Health, Other Health, Other Science, Pharmaceutical, Science, Biotechnology, Group, Solution, Stevanato Group, NYSE, Bank, Conference, BST, Biotechnology, Engineering, Fine chemical
Geotags: 
NEW YORK, NORTH AMERICA, UNITED STATES, UNITED KINGDOM, EUROPE, ITALY, LONDON
Stock Symbol: 
NYSE:STVN
Summary
Key Points: 
  • Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that management will present at the Bank of America Global Healthcare Conference in London at 9:05 a.m. (BST) on September 15, 2022.
  • A webcast will be available on the investor section of the Companys website, www.stevanatogroup.com , under the News & Events tab.
  • Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries.
  • The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages.


Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that management will present at the Bank of America Global Healthcare Conference in London at 9:05 a.m. (BST) on September 15, 2022.

A webcast will be available on the investor section of the Company’s website, www.stevanatogroup.com, under the “News & Events” tab.

About Stevanato Group

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.

For more information, please visit www.stevanatogroup.com.

Copyright: 
Copyright Business Wire 2022